CTSB and glioblastoma: On the other hand, reduced CtsB expression has been shown to reduce glioma [27], osteosarcoma [28], and mammary cancer [29] cell malignancy, while a low StfA expression was associated with glioblastoma [30], breast [31], and head and neck cancer progression [32].